Electroacupuncture efficacy in diabetic polyneuropathy: Study protocol for a double-blinded randomized controlled multicenter clinical trial
Tóm tắt
Diabetic peripheral neuropathy (DPN) is the most common complication of type 2 diabetes mellitus (T2DM); its diagnosis and treatment are based on symptomatic improvement. However, as pharmacological therapy causes multiple adverse effects, the implementation of acupunctural techniques, such as electroacupuncture (EA) has been suggested as an alternative treatment. Nonetheless, there is a lack of scientific evidence, and its mechanisms are still unclear. We present the design and methodology of a new clinical randomized trial, that investigates the effectiveness of EA for the treatment of DPN. This study is a four-armed, randomized, controlled, multicenter clinical trial (20-week intervention period, plus 12 weeks of follow-up after concluding intervention). A total of 48 T2DM patients with clinical signs and symptoms of DPN; and electrophysiological signs in the Nerve Conduction Study (NCS); will be treated by acupuncture specialists in outpatient units in Mexico City. Patients will be randomized in a 1:1 ratio to one of the following four groups: (a) short fibre DPN with EA, (b) short fibre DPN with sham EA, (c) axonal DPN with EA and (d) axonal DPN with sham EA treatment. The intervention will consist of 32 sessions, 20 min each, per patient over two cycles of intervention of 8 weeks each and a mid-term rest period of 4 weeks. The primary outcome will be NCS parameters, and secondary outcomes will include DPN-related symptoms and pain by Michigan Neuropathy Screening Instrument (MNSI), Michigan Diabetic Neuropathy Score (MDNS), Dolour Neuropatique Score (DN-4), Semmes-Westein monofilament, Numerical Rating Scale (NRS) for pain assessment, and the 36-item Short Form Health Survey (SF-36). To measure quality of life and improve oxidative stress, the inflammatory response; and genetic expression; will be analysed at the beginning and at the end of treatment. This study will be conducted to compare the efficacy of EA versus sham EA combined with conventional diabetic and neuropathic treatments if needed. EA may improve NCS, neuropathic pain and symptoms, oxidative stress, inflammatory response, and genetic expression, and it could be considered a potential coadjutant treatment for the management of DPN with a possible remyelinating effect. ClinicalTrials.gov. NCT05521737 Registered on 30 August 2022. International Clinical Trials Registry Platform (ICTRP) ISRCTN97391213 Registered on 26 September 2022 [2b].
Tài liệu tham khảo
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE, Bright D, Williams R, IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843.
Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2023;402(10397):203–34.
Trimestre T, Epidemiol V, Transmisibles EN. Informe Trimestral de Vigilancia Epidemiológica Hospitalaria Diabetes Mellitus Tipo 2. 2021.
Basto-Abreu A, López-Olmedo N, Rojas-Martínez R, Aguilar-Salinas CA, de la Cruz-Góngora V, Rivera-Dommarco J, et al. Prevalence of diabetes and glycemic control in Mexico: national results from 2018 and 2020. Salud Publica Mex. 2021;63(6):725–33.
Pop-Busui R, Boulton AJM, Feldman EL, Bril V, Freeman R, Malik RA, et al. Diabetic neuropathy: a position statement by the American diabetes association. Diabetes Care. 2017;40(1):136–54.
Alberti KGMM, Webber S, Federation ID, International Diabetes Federation, IDF, International Diabetes Federation, et al. Idf Atlas Reports. Curr status Prev Treat Diabet Complicat Proc Third Int Symp Treat Diabetes Mellitus ICS821. 2022;102(2):147–8.
Sun J, Wang Y, Zhang X, Zhu S, He H. Prevalence of peripheral neuropathy in patients with diabetes: a systematic review and meta-analysis. Prim Care Diabetes. 2020;14(5):435–44.
Yovera-Aldana M, Velasquez-Rimachi V, Huerta-Rosario A, More-Yupanqui MD, Osores-Flores M, Espinoza R, et al. Prevalence and incidence of diabetic peripheral neuropathy in Latin America and the Caribbean: a systematic review and metaanalysis. PLoS One. 2021;16(5 May):1–29.
Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, et al. Diabetic neuropathy. Nat Rev Dis Prim. 2019;5(1):42.
Pop-Busui R, Ang L, Holmes C, Gallagher K, Feldman EL. Inflammation as a therapeutic target for diabetic neuropathies. Curr Diab Rep. 2016;16(3):1–10.
Tang HY, Jiang AJ, Ma JL, Wang FJ, Shen GM. Understanding the signaling pathways related to the mechanism and treatment of diabetic peripheral neuropathy. Endocrinology. 2019;160(9):2119–27.
Zhou J, Zhou S. Inflammation: Therapeutic targets for diabetic neuropathy. Mol Neurobiol. 2014;49(1):536–46.
Ismail CAN, Aziz CBA, Suppian R, Long I. Imbalanced oxidative stress and pro-inflammatory markers differentiate the development of diabetic neuropathy variants in streptozotocin-induced diabetic rats. J Diabetes Metab Disord. 2018;17(2):129–36.
Gonçalves NP, Vægter CB, Andersen H, Østergaard L, Calcutt NA, Jensen TS. Schwann cell interactions with axons and microvessels in diabetic neuropathy. Nat Rev Neurol. 2017;13:135–47 Nature Publishing Group.
Li X, Zhu J, Liu N, Liu J, Zhang Z. TNF-Alpha in peripheral neuropathy patients with impaired glucose regulation. J Diabetes Res. 2017;2017:7024024.
Elafros MA, Andersen PH, Bennett PDL, Masha G, Viswanathan PV, Callaghan BC, et al. Clinical presentation , pathogenesis , and treatment of diabetic neuropathy. 2022.
Ziegler D, Landgraf R, Lobmann R, Reiners K, Rett K, Schnell O, et al. Painful and painless neuropathies are distinct and largely undiagnosed entities in subjects participating in an educational initiative (PROTECT study). Diabetes Res Clin Pract. 2018;139:147–54.
Ziegler D, Tesfaye S, Spallone V, Gurieva I, Al Kaabi J, Mankovsky B, et al. Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations. Diabetes Res Clin Pract. 2022;186:109063.
Chicharro-Luna E, Pomares-Gómez FJ, Ortega-Ávila AB, Coheña-Jiménez M, Gijon-Nogueron G. Variability in the clinical diagnosis of diabetic peripheral neuropathy. Prim Care Diabetes. 2020;14(1):53–60.
Tesfaye S, Boulton AJM, Dyck PJ, Freeman R, Horowitz M, Kempler P, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285–93.
Lin YC, Lin CSY, Chang TS, Lee JE, Tani J, Chen HJ, et al. Early sensory neurophysiological changes in prediabetes. J Diabetes Investig. 2020;11(2):458–65.
Marshall A, Alam U, Themistocleous A, Calcutt N, Marshall A. Novel and emerging electrophysiological biomarkers of diabetic neuropathy and painful diabetic neuropathy. Clin Ther. 2021;43(9):1441–56.
Stępień J, Pastuszak Ż. Distal symmetrical polyneuropathy in diabetes mellitus patients: Proposition of a new scoring system based on electroneurography findings. Adv Clin Exp Med. 2023;33(4):0–0.
Sloan G, Selvarajah D, Tesfaye S. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nat Rev Endocrinol. 2021;17(7):400–20.
Karonova T, Stepanova A, Bystrova A, Jude EB. High-dose vitamin d supplementation improves microcirculation and reduces inflammation in diabetic neuropathy patients. Nutrients. 2020;12(9):1–10.
Cho E, Kim W. Effect of acupuncture on diabetic neuropathy: a narrative review. Int J Mol Sci. 2021;22:8575 MDPI AG.
Dietzel J, Habermann IV, Hörder S, Hahn K, Meyer-Hamme G, Ortiz M, et al. Acupuncture in patients with diabetic peripheral neuropathy-related complaints: a randomized controlled clinical trial. J Clin Med. 2023;12(6):2103.
Li X, Liu Y, Jing Z, Fan B, Pan W, Mao S, et al. Effects of acupuncture therapy in diabetic neuropathic pain: a systematic review and meta-analysis. Complement Ther Med. 2023;78(September):102992.
Meyer-Hamme G, Friedemann T, Greten J, Gerloff C, Schroeder S. Electrophysiologically verified effects of acupuncture on diabetic peripheral neuropathy in type 2 diabetes: the randomized, partially double-blinded, controlled ACUDIN trial. J Diabetes. 2021;13(6):469–81.
Jin BX, Jin LL, Jin G-Y. The anti-inflammatory effect of acupuncture and its significance in analgesia. World J Acupunct - Moxibustion. 2019;29(1):1–6.
Wang Z, Hou Y, Huang Y, Ju F, Liang Z, Li S. Clinical efficacy and safety of electro acupuncture combined with beraprost sodium and α-lipoic acid for diabetic peripheral neuropathy. Am J Transl Res. 2022;14(1):612–22.
Wang JY, Gao YH, Qiao LN, Zhang JL, Duan-Mu CL, Yan YX, et al. Repeated electroacupuncture treatment attenuated hyperalgesia through suppression of spinal glial activation in chronic neuropathic pain rats. BMC Complement Altern Med. 2018;18(1):1–11.
Butcher NJ, Monsour A, Mew EJ, Chan AW, Moher D, Mayo-Wilson E, et al. Guidelines for reporting outcomes in trial reports: the CONSORT-Outcomes 2022 Extension. JAMA. 2022;328(22):2252–64.
MacPherson H, Altman DG, Hammerschlag R, White A, Moher D. Revised Standards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): Extending the CONSORT statement. Chinese J Evidence-Based Med. 2010;10(10):1228–39.
Lian Y-L. Atlas gráfico de acupuntura: representación de los puntos de acupuntura. Germany: H.F. Ullmann; 2006.
Sun ZG, Pi YL, Zhang J, Wang M, Zou J, Wu W. Effect of acupuncture at ST36 on motor cortical excitation and inhibition. Brain Behav. 2019;9(9):1–8.
Xing JJ, Zeng BY, Li J, Zhuang Y, Liang FR. Acupuncture point specificity. 1st ed. Int Rev Neurobiol. 2013;111:49–65 Elsevier Inc.
Takamoto K, Urakawa S, Sakai K, Ono T, Nishijo H. Effects of acupuncture needling with specific sensation on cerebral hemodynamics and autonomic nervous activity in humans. 1st ed. Int Rev Neurobiol. 2013;111:25–48 Elsevier Inc.
Chen L, Yin T, He Z, Chen Y, Sun R, Lu J, et al. Deqi sensation to predict acupuncture effect on functional dyspepsia: a machine learning study. Evid -Based Complement Altern Med. 2022;2022:4824575.
Morris et al. 2012, NIH Public Access. Gerontol. 2015;61(6):515–25.
Ticse R, Pimentel R, Mazzeti P, Villena J. Elevada frecuencia de neuropatía periférica en pacientes con Diabetes mellitus tipo 2 de un hospital general de Lima-Perú. Rev Med Hered. 2013;24(2):114–21.
Spallone V, Morganti R, D’Amato C, Greco C, Cacciotti L, Marfia GA. Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. Diabet Med. 2012;29(5):578–85.
Karcioglu O, Topacoglu H, Dikme O, Dikme O. A systematic review of the pain scales in adults: Which to use? Am J Emerg Med. 2018;36(4):707–14.
Açma A, Carrat F, Hejblum G. Comparing SF-36 Scores Collected Through Web-Based Questionnaire Self-completions and Telephone Interviews: An Ancillary Study of the SENTIPAT Multicenter Randomized Controlled Trial. J Med Internet Res. 2022;24(3):1–21.
Yagi K. [39] Assay for Blood Plasma or Serum. Methods Enzymol. 1984;105(C):328–31.
Zhao YX, Yao MJ, Liu Q, Xin JJ, Gao JH, Yu XC. Electroacupuncture treatment attenuates paclitaxel-induced neuropathic pain in rats via inhibiting spinal glia and the TLR4/NF-κB pathway. J Pain Res. 2020;13:239–50.
Carlsson C, Wallengren J. Therapeutic and experimental therapeutic studies on acupuncture and itch: Review of the literature. J Eur Acad Dermatology Venereol. 2010;24(9):1013–6.